Please find enclosed Investor Presentation
COLPAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Colgate-Palmolive (India) held its Q4 & FY26 analyst call on May 22, 2026. Q4 FY26 showed strong recovery with Net Sales of ₹1,583 crore (+9.2% YoY) and NPAT of ₹353 crore (+9.2% YoY). Gross margin stood at 69.6% with EBITDA margin at 32.2%. Full year FY26 Net Sales was ₹5,984 crore (flat YoY) with NPAT of ₹1,325 crore (-1.8% YoY), impacted by GST-led inverted duty changes (~160 bps impact in Q4) and one-off items. H2 FY26 showed sharp recovery with 5.2% NS growth. Brand investments were increased to ₹819 crore (13.7% of NS) for FY26. The company highlighted superior margin profile vs peers, ongoing cost-efficiency initiatives under 'Funding the Growth' programme, and continued premiumisation drive across toothpaste, toothbrush, and personal care. Key strategic pillars include accelerating oral care premiumisation (Colgate Total, Visible White), leadership in toothbrush, and building personal care (handwash).
Colgate delivered a strong Q4 bounce-back after a subdued FY26, with margin resilience and brand investment acceleration signalling management confidence in sustained competitive strength. The flat-to-negative FY26 topline and NPAT may weigh on near-term sentiment despite the sequential H2 recovery.